. Efficacité-et-tolérance-À-long-terme-de-béhérec, Etude rétrospective de l'efficacité et de la tolérance de la clozapine sur les comportementsdéfis des patients adultes avec TSA : réplication de l, p.46

A. Zuddas, M. Ledda, A. Fratta, P. Muglia, and C. Cianchetti, Clinical effects of clozapine on autistic disorder, Am J Psychiatry, vol.153, issue.5, p.738, 1996.

G. Gobbi and L. Pulvirenti, Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour, J Psychiatry Neurosci JPN, vol.26, issue.4, pp.340-341, 2001.

N. Chen, H. Bedair, B. Mckay, M. Bowers, and C. Mazure, Clozapine in the Treatment of Aggression in an Adolescent With Autistic Disorder, The Journal of Clinical Psychiatry, vol.62, issue.6, pp.479-80, 2001.
DOI : 10.4088/JCP.v62n0612h

S. Lambrey, B. Falissard, M. Martin-barrero, C. Bonnefoy, G. Quilici et al., Effectiveness of Clozapine for the Treatment of Aggression in an Adolescent with Autistic Disorder, Journal of Child and Adolescent Psychopharmacology, vol.20, issue.1, pp.79-80, 2010.
DOI : 10.1089/cap.2009.0057

L. Béhérec, S. Lambrey, Q. Quilici, A. Rosier, B. Falissard et al., Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors, Journal of Clinical Psychopharmacology, vol.31, issue.3, pp.341-345, 2011.
DOI : 10.1097/JCP.0b013e318218f4a1

H. Gunes, C. Tanidir, and A. Erdogan, Effective Use of Aripiprazole Augmentation in a Clozapine-Treated Adolescent with Autism Spectrum Disorder, Journal of Child and Adolescent Psychopharmacology, vol.25, issue.9, pp.727-735, 2015.
DOI : 10.1089/cap.2015.0101

O. Yalcin, G. Kaymak, A. Erdogan, C. Tanidir, G. Karacetin et al., A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey, Journal of Child and Adolescent Psychopharmacology, vol.26, issue.9, pp.815-836, 2016.
DOI : 10.1089/cap.2015.0020

S. Sahoo, S. Padhy, N. Singla, and A. Singh, Effectiveness of clozapine for the treatment of psychosis and disruptive behaviour in a child with Atypical Autism: A case report and a brief review of the evidence, Asian Journal of Psychiatry, vol.29
DOI : 10.1016/j.ajp.2017.07.012

L. Kanner, Autistic disturbances of affective contact In: Nervous Child, pp.217-50, 1943.

O. Mondiale-de and L. Santé, Classification statistique internationale des maladies et des problèmes de santé connexes. 10ème révision, Genève : OMS, 1999.

R. Misès, Classification Française des Troubles Mentaux de l'Enfant et de l'Adolescent : CFTMEA -R- 2012, 2012.

L. Wing, The relationship between Asperger's syndrome and Kanner's autism, 1991.
DOI : 10.1017/CBO9780511526770.003

G. Vivanti, P. Vivanti, and D. , Les nouveaux critères diagnostiques du DSM-5. Link Autisme-Eur. 2013 décembre, pp.8-10

T. Brugha, S. Mcmanus, H. Meltzer, J. Smith, F. J. Scott et al., Autism Spectrum disorders in adults living in households throughout England. Report from the Adult Psychiatric Morbidity Survey, National Centre for Social Research, 2007.

E. Fombonne, Epidemiology of Pervasive Developmental Disorders, Pediatric Research, vol.364, issue.6, pp.591-599, 2009.
DOI : 10.1016/S0140-6736(04)17020-7

E. Fombonne, D. Mazaubrun, C. Cans, C. Grandjean, and H. , Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry, pp.1561-1570, 1997.

E. Fombonne, The epidemiology of autism: a review, Psychological Medicine, vol.29, issue.4, pp.769-86, 1999.
DOI : 10.1017/S0033291799008508

E. Fombonne, Epidemiological surveys of autism and other pervasive developmental disorders: an update, Journal of Autism and Developmental Disorders, vol.33, issue.4, pp.365-82, 2003.
DOI : 10.1023/A:1025054610557

E. Fombonne, Epidemiology of autistic disorder and other pervasive developmental disorders, J Clin Psychiatry, vol.66, issue.10, pp.3-8, 2005.

M. King and P. Bearman, Diagnostic change and the increased prevalence of autism, International Journal of Epidemiology, vol.42, issue.5, 2009.
DOI : 10.2307/2531248

D. Christensen, J. Baio, K. Van-naarden-braun, D. Bilder, C. J. Constantino et al., Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, Morb Mortal Wkly Rep Surveill Summ, vol.65, issue.3, pp.1-23, 2002.

K. Hume, R. Loftin, and J. Lantz, Increasing Independence in Autism Spectrum Disorders: A Review of Three Focused Interventions, Journal of Autism and Developmental Disorders, vol.37, issue.19, pp.1329-1367, 2009.
DOI : 10.1007/s10803-006-0300-1

P. Shattuck, M. Seltzer, J. Greenberg, G. Orsmond, D. Bolt et al., Change in Autism Symptoms and Maladaptive Behaviors in Adolescents and Adults with an Autism Spectrum Disorder, Journal of Autism and Developmental Disorders, vol.26, issue.5, pp.1735-1782, 2007.
DOI : 10.4135/9781849208512

B. Chamak and B. Bonniau, Trajectories, Long-Term Outcomes and Family Experiences of 76 Adults with Autism Spectrum Disorder, Journal of Autism and Developmental Disorders, vol.2, issue.2, pp.1084-95, 2016.
DOI : 10.1007/978-1-4757-9345-1_16

C. Mcgovern and M. Sigman, Continuity and change from early childhood to adolescence in autism, Journal of Child Psychology and Psychiatry, vol.63, issue.4, pp.401-409, 2005.
DOI : 10.1023/A:1014884404276

P. Howlin, S. Goode, J. Hutton, and M. Rutter, Adult outcome for children with autism, Journal of Child Psychology and Psychiatry, vol.33, issue.2, pp.212-241, 2004.
DOI : 10.1017/CBO9780511526770.005

F. Cazalis, Ces femmes autistes qui s'ignorent [Internet]. The Conversation, 2017.

R. Loomes, L. Hull, and W. Mandy, What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry, pp.466-74, 2017.

A. Kolevzon, R. Gross, and A. Reichenberg, Prenatal and Perinatal Risk Factors for Autism, Archives of Pediatrics & Adolescent Medicine, vol.161, issue.4, pp.326-359, 2007.
DOI : 10.1001/archpedi.161.4.326

M. Brimacombe, X. Ming, and M. Lamendola, Prenatal and Birth Complications in Autism, Maternal and Child Health Journal, vol.61, issue.6, pp.73-82, 2007.
DOI : 10.1212/WNL.58.3.428

M. Ng, J. De-montigny, M. Ofner, and M. Do, Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013. Health Promot Chronic Dis Prev Can Res Policy Pract, pp.1-23, 2017.

J. Grether, M. Anderson, L. Croen, D. Smith, and G. Windham, Risk of Autism and Increasing Maternal and Paternal Age in a Large North American Population, American Journal of Epidemiology, vol.114, issue.7, pp.1118-1144, 2009.
DOI : 10.1007/BF02172145

M. King, C. Fountain, D. Dakhlallah, and P. Bearman, Estimated Autism Risk and Older Reproductive Age, American Journal of Public Health, vol.99, issue.9, pp.1673-1682, 2009.
DOI : 10.2105/AJPH.2008.149021

URL : http://europepmc.org/articles/pmc2724463?pdf=render

T. Becerra, M. Wilhelm, J. Olsen, M. Cockburn, and B. Ritz, Ambient air pollution and autism in Los Angeles county, California. Environ Health Perspect, pp.380-386, 2013.

H. Volk, F. Lurmann, B. Penfold, I. Hertz-picciotto, and R. Mcconnell, Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry, pp.71-78, 2013.
DOI : 10.1001/jamapsychiatry.2013.266

URL : http://archpsyc.jamanetwork.com/data/journals/psych/926165/yoa120028_71_77.pdf

J. Christensen, T. Grønborg, M. Sørensen, D. Schendel, E. Parner et al., Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism, JAMA, vol.309, issue.16, pp.1696-703, 2013.
DOI : 10.1001/jama.2013.2270

L. Croen, J. Grether, C. Yoshida, R. Odouli, and V. Hendrick, Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry, pp.1104-1116, 2011.
DOI : 10.1001/archgenpsychiatry.2011.73

URL : http://archpsyc.jamanetwork.com/data/journals/psych/22580/yoa15049_1104_1112.pdf

D. Rai, B. Lee, C. Dalman, J. Golding, G. Lewis et al., Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study, BMJ, vol.346, issue.apr19 1, p.2059
DOI : 10.1136/bmj.f2059

L. Smeeth, C. Cook, E. Fombonne, L. Heavey, L. Rodrigues et al., MMR vaccination and pervasive developmental disorders: a case-control study, The Lancet, vol.364, issue.9438, pp.963-972, 2004.
DOI : 10.1016/S0140-6736(04)17020-7

P. Bolton, H. Macdonald, A. Pickles, P. Rios, S. Goode et al., A Case-Control Family History Study of Autism, Journal of Child Psychology and Psychiatry, vol.47, issue.5, pp.877-900, 1994.
DOI : 10.1016/0304-4076(82)90100-2

A. Bailey, L. Couteur, A. Gottesman, I. Bolton, P. Simonoff et al., Autism as a strongly genetic disorder: evidence from a British twin study, Psychological Medicine, vol.134, issue.01, pp.63-77, 1995.
DOI : 10.1111/j.1469-7610.1994.tb01164.x

S. Steffenburg, C. Gillberg, L. Hellgren, L. Andersson, I. Gillberg et al., A Twin Study of Autism in Denmark, Finland, Iceland, Norway and Sweden, Journal of Child Psychology and Psychiatry, vol.149, issue.3, 1989.
DOI : 10.1007/BF01531288

E. Colvert, B. Tick, F. Mcewen, C. Stewart, S. Curran et al., Heritability of Autism Spectrum Disorder in a UK Population-Based Twin Sample, JAMA Psychiatry, vol.72, issue.5, pp.415-438
DOI : 10.1001/jamapsychiatry.2014.3028

J. Matson and M. Shoemaker, Intellectual disability and its relationship to autism spectrum disorders, Research in Developmental Disabilities, vol.30, issue.6, pp.1107-1121, 2009.
DOI : 10.1016/j.ridd.2009.06.003

J. Matson, B. Smiroldo, and T. Hastings, Validity of the Autism/Pervasive Developmental Disorder subscale of the Diagnostic Assessment for the Severely Handicapped-II, J Autism Dev Disord, 1998.

M. Yeargin-allsopp, C. Rice, T. Karapurkar, N. Doernberg, C. Boyle et al., Prevalence of Autism in a US Metropolitan Area, JAMA, vol.289, issue.1, pp.49-55, 2003.
DOI : 10.1001/jama.289.1.49

S. Chakrabarti and E. Fombonne, Pervasive Developmental Disorders in Preschool Children: Confirmation of High Prevalence, American Journal of Psychiatry, vol.162, issue.6, pp.1133-1174, 2005.
DOI : 10.1176/appi.ajp.162.6.1133

S. Bryson, E. Bradley, A. Thompson, and A. Wainwright, Prevalence of Autism among Adolescents with Intellectual Disabilities, The Canadian Journal of Psychiatry, vol.12, issue.6, pp.449-59, 2008.
DOI : 10.1023/A:1005605528309

J. Matson and M. Nebel-schwalm, Comorbid psychopathology with autism spectrum disorder in children: an overview. Res Dev Disabil, pp.341-52, 2007.

H. Autorité and D. Santé, Autisme et autres troubles envahissants du développement. Etat des connaissances hors mécanismes physiopathologiques, psychopathologiques et recherche fondamentale. HAS, 2010.

A. Baghdadli, V. Gonnier, and C. Aussilloux, Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. L'Encephale, pp.248-54, 2002.

M. Fernández, I. Mollinedo-gajate, and O. Peñagarikano, Neural Circuits for Social Cognition: Implications for Autism, Neuroscience, vol.370, 2017.
DOI : 10.1016/j.neuroscience.2017.07.013

K. Yenkoyan, A. Grigoryan, K. Fereshetyan, and D. Yepremyan, Advances in understanding the pathophysiology of autism spectrum disorders, Behavioural Brain Research, vol.331, pp.92-101, 2017.
DOI : 10.1016/j.bbr.2017.04.038

H. Autorité and D. Santé, Autisme et autres troubles envahissants du développement : interventions éducatives et thérapeutiques coordonnées chez l'enfant et l'adolescent. HAS, 2012.

A. Baghdadli, M. Noyer, and C. Aussilloux, Interventions éducatives, pédagogiques et thérapeutiques proposées dans l'autisme, 2007.

R. Condillac and A. Perry, Pratiques fondées sur les résultats s'appliquant aux enfants et aux adolescents atteints de troubles du spectre autistique : examen des travaux de recherche et guide pratique, 2003.

R. Hastings, H. Kovshoff, N. Ward, F. Degli-espinosa, T. Brown et al., Systems Analysis of Stress and Positive Perceptions in Mothers and Fathers of Pre-School Children with Autism, Journal of Autism and Developmental Disorders, vol.67, issue.5, pp.635-679, 2005.
DOI : 10.1007/s10803-005-0007-8

L. Lecavalier, Behavioral and Emotional Problems in Young People with Pervasive Developmental Disorders: Relative Prevalence, Effects of Subject Characteristics, and Empirical Classification, Journal of Autism and Developmental Disorders, vol.289, issue.8, pp.1101-1115, 2006.
DOI : 10.3109/08039488909101971

M. Brien, J. A. Felce, and D. , Working with people who have severe learning difficulties and challenging behavior. A practical handbook on the behavioural approach. Kidderminster : British Institute of Mental Handicap, 1992.

R. Didden, P. Duker, and H. Korzilius, Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation, Am J Ment Retard AJMR, vol.101, issue.4, pp.387-99, 1997.

E. Emerson, Challenging Behaviour: Analysis and Intervention in People with Learning Disabilities, 1995.

J. Graetz, Autism grows up: opportunities for adults with autism, Disability & Society, vol.34, issue.1, pp.33-47, 2010.
DOI : 10.1111/j.1365-2788.2005.00739.x

P. Mcgill and J. Poynter, High Cost Residential Placements for Adults with Intellectual Disabilities, Journal of Applied Research in Intellectual Disabilities, vol.51, issue.6, pp.584-591
DOI : 10.1111/j.1365-2788.2006.00852.x

C. Herzinger and J. Campbell, Comparing Functional Assessment Methodologies: A Quantitative Synthesis, Journal of Autism and Developmental Disorders, vol.23, issue.8, pp.1430-1475, 2007.
DOI : 10.1176/appi.books.9780890423349

F. Tyrer, C. Mcgrother, C. Thorp, M. Donaldson, S. Bhaumik et al., Physical aggression towards others in adults with learning disabilities: prevalence and associated factors, Journal of Intellectual Disability Research, vol.1, issue.4, pp.295-304, 2006.
DOI : 10.1046/j.1365-2788.2002.00397.x

L. Lecavalier, S. Leone, and J. Wiltz, The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders, Journal of Intellectual Disability Research, vol.56, issue.3, pp.172-83, 2006.
DOI : 10.1111/j.2044-8325.1983.tb00106.x

D. Mandell, Psychiatric Hospitalization Among Children with Autism Spectrum Disorders, Journal of Autism and Developmental Disorders, vol.101, issue.5, pp.1059-65, 2008.
DOI : 10.1016/S0890-8567(99)80003-3

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862976/pdf

S. Kanne and M. Mazurek, Aggression in Children and Adolescents with ASD: Prevalence and Risk Factors, Journal of Autism and Developmental Disorders, vol.16, issue.2, pp.926-963, 2011.
DOI : 10.1080/10409289.2005.10472870

L. Szymanski and . Dc-ld, DC-LD (Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation). Royal College of Psychiatrists Occasional Paper OP 48, Gaskell, London. 2001. 128 pp., Journal of Intellectual Disability Research, vol.46, issue.6, pp.525-532, 2002.
DOI : 10.1046/j.1365-2788.2002.00403.x

S. A. Borthwick-duffy, Prevalence of destructive behaviours : a study of aggression, self-injury and property destruction In: Destructive behavior in developmental disabilities : diagnosis and treatment, pp.3-23, 1994.

S. Cooper, E. Smiley, L. Allan, A. Jackson, J. Finlayson et al., Adults with intellectual disabilities: prevalence, incidence and remission of self-injurious behaviour, and related factors, Journal of Intellectual Disability Research, vol.51, issue.3, pp.200-216, 2009.
DOI : 10.1111/j.1468-3148.1992.tb00041.x

S. Cooper, E. Smiley, A. Jackson, J. Finlayson, L. Allan et al., Adults with intellectual disabilities: prevalence, incidence and remission of aggressive behaviour and related factors, Journal of Intellectual Disability Research, vol.162, issue.3, pp.217-249, 2009.
DOI : 10.1111/j.1468-3148.1992.tb00041.x

K. Mcclintock, S. Hall, and C. Oliver, Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study, Journal of Intellectual Disability Research, vol.309, issue.6, pp.405-421, 2003.
DOI : 10.1136/bmj.309.6965.1351

E. Tsakanikos, H. Costello, G. Holt, P. Sturmey, and N. Bouras, Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism, Journal of Autism and Developmental Disorders, vol.37, issue.6, pp.1080-1085, 2007.
DOI : 10.4324/9780203426913

S. Fitzpatrick, L. Srivorakiat, L. Wink, E. Pedapati, and C. Erickson, Aggression in autism spectrum disorder: presentation and treatment options, Neuropsychiatr Dis Treat, vol.12, pp.1525-1563, 2016.

N. Minshawi, S. Hurwitz, J. Fodstad, S. Biebl, D. Morriss et al., The association between self-injurious behaviors and autism spectrum disorders, Psychology Research and Behavior Management, vol.7, pp.125-161, 2014.
DOI : 10.2147/PRBM.S44635

J. Mccarthy, C. Hemmings, E. Kravariti, K. Dworzynski, G. Holt et al., Challenging behavior and co-morbid psychopathology in adults with intellectual disability and autism spectrum disorders, Research in Developmental Disabilities, vol.31, issue.2, pp.362-368, 2010.
DOI : 10.1016/j.ridd.2009.10.009

K. Dominick, N. Davis, J. Lainhart, H. Tager-flusberg, and S. Folstein, Atypical behaviors in children with autism and children with a history of language impairment, Research in Developmental Disabilities, vol.28, issue.2, pp.145-62, 2007.
DOI : 10.1016/j.ridd.2006.02.003

S. Hartley, D. Sikora, and R. Mccoy, Prevalence and risk factors of maladaptive behaviour in young children with Autistic Disorder, Journal of Intellectual Disability Research, vol.15, issue.10, pp.819-848, 2008.
DOI : 10.1176/appi.books.9780890423349

D. Périsse, V. Guinchat, J. Hellings, and A. Baghdadli, Traitement pharmacologique des comportements probl??matiques associ??s aux troubles du spectre autistique??: revue de la litt??rature, Neuropsychiatrie de l'Enfance et de l'Adolescence, vol.60, issue.1, pp.42-51, 2012.
DOI : 10.1016/j.neurenf.2011.10.011

A. Centre-expertise and . Adultes, Investigations somatiques pour adultes avec autisme. Aide à la démarche, 2012.

H. Autorité and D. Santé, Autisme et autres troubles envahissants du développement : diagnostic et évaluation chez l'adulte. Argumentaire scientifique. HAS, 2011.

M. Ospina, K. Seida, J. Clark, B. Karkhaneh, M. Hartling et al., Behavioural and Developmental Interventions for Autism Spectrum Disorder: A Clinical Systematic Review, PLoS ONE, vol.74, issue.1, p.3755, 2008.
DOI : 10.1371/journal.pone.0003755.s002

M. Defilippis and K. Wagner, Treatment of Autism Spectrum Disorder in Children and Adolescents, Psychopharmacol Bull Aug, vol.1546, issue.2, pp.18-41, 2016.

F. Kevan, Challenging behaviour and communication difficulties, British Journal of Learning Disabilities, vol.21, issue.2, pp.75-80, 2003.
DOI : 10.1108/13595474199700032

M. Seltzer, P. Shattuck, L. Abbeduto, and J. Greenberg, Trajectory of development in adolescents and adults with autism, Mental Retardation and Developmental Disabilities Research Reviews, vol.19, issue.4, pp.234-281, 2004.
DOI : 10.1176/ajp.154.2.185

S. Myers, The status of pharmacotherapy for autism spectrum disorders, Expert Opinion on Pharmacotherapy, vol.19, issue.11, pp.1579-603, 2007.
DOI : 10.1176/appi.psy.47.1.75

A. Esbensen, J. Greenberg, M. Seltzer, and M. Aman, A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders, Journal of Autism and Developmental Disorders, vol.15, issue.9, pp.1339-1388, 2009.
DOI : 10.1007/s10803-009-0750-3

G. Kaplan and J. Mccracken, Psychopharmacology of autism spectrum disorders. Pediatr Clin North Am, Feb, vol.59, issue.1, pp.175-187, 2012.

J. Volavka, The Neurobiology of Violence, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.11, issue.3, pp.307-321, 1999.
DOI : 10.1176/jnp.11.3.307

B. King, Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders, Journal of Autism and Developmental Disorders, vol.30, issue.5, pp.439-484, 2000.
DOI : 10.1023/A:1005555624566

M. Fankhauser, V. Karumanchi, M. German, A. Yates, and S. Karumanchi, A double-blind, placebocontrolled study of the efficacy of transdermal clonidine in autism, J Clin Psychiatry, 1992.

C. Jaselskis, E. Cook, K. Fletcher, and B. Leventhal, Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder, Journal of Clinical Psychopharmacology, vol.12, issue.5, pp.322-329, 1992.
DOI : 10.1097/00004714-199210000-00005

B. Handen, R. Sahl, and A. Hardan, Guanfacine in Children with Autism and/or Intellectual Disabilities, Journal of Developmental & Behavioral Pediatrics, vol.29, issue.4, pp.303-311, 2008.
DOI : 10.1097/DBP.0b013e3181739b9d

L. Scahill, J. Mccracken, B. King, C. Rockhill, B. Shah et al., Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder, American Journal of Psychiatry, vol.172, issue.12, 2015.
DOI : 10.1176/appi.ajp.2015.15010055

J. Ratey, J. Bemporad, P. Sorgi, P. Bick, S. Polakoff et al., Brief report: Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults, Journal of Autism and Developmental Disorders, vol.15, issue.1, pp.439-485, 1987.
DOI : 10.1007/BF01487073

A. Hardan and B. Handen, A Retrospective Open Trial of Adjunctive Donepezil in Children and Adolescents with Autistic Disorder, Journal of Child and Adolescent Psychopharmacology, vol.12, issue.3, pp.237-278, 2002.
DOI : 10.1089/104454602760386923

M. Chez, T. Buchanan, M. Becker, J. Kessler, M. Aimonovitch et al., Donepezil hydrochloride: a double-blind study in autistic children, J Pediatr Neurol, vol.1, issue.2, pp.83-91, 2003.

A. Ghaleiha, M. Ghyasvand, M. Mohammadi, M. Farokhnia, N. Yadegari et al., Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial, Journal of Psychopharmacology, vol.21, issue.7, pp.677-85
DOI : 10.1093/hmg/ddr357

H. Niederhofer, W. Staffen, and A. Mair, Galantamine may be effective in treating autistic disorder, BMJ, vol.325, issue.7377, p.1422, 2002.
DOI : 10.1136/bmj.325.7377.1422/a

URL : http://europepmc.org/articles/pmc1124870?pdf=render

H. Niederhofer, Treating Autism Pharmacologically: Also Tacrine Might Improve Symptomatology in Some Cases, Journal of Child Neurology, vol.39, issue.8, pp.1054-1054, 2007.
DOI : 10.2190/JE5Q-1NFT-FL40-7PMW

A. Ghaleiha, M. Asadabadi, M. Mohammadi, M. Shahei, M. Tabrizi et al., Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial, The International Journal of Neuropsychopharmacology, vol.30, issue.04, pp.783-792, 2013.
DOI : 10.2174/157488507780619095

B. King, D. Wright, B. Handen, L. Sikich, A. Zimmerman et al., Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, vol.40, issue.6, pp.658-65, 2001.
DOI : 10.1097/00004583-200106000-00010

E. Lemonnier, N. Villeneuve, S. Sonie, S. Serret, A. Rosier et al., Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders. Transl Psychiatry, p.1056, 2017.

D. Geier, J. Kern, G. Davis, P. King, J. Adams et al., A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders, Medical Science Monitor, vol.17, issue.6, pp.15-23, 2011.
DOI : 10.12659/MSM.881792

M. Fink, M. Taylor, and N. Ghaziuddin, Catatonia in Autistic Spectrum Disorders: A Medical Treatment Algorithm, Int Rev Neurobiol, vol.72, pp.233-277, 2006.
DOI : 10.1016/S0074-7742(05)72014-6

H. Bruining, L. Passtoors, N. Goriounova, F. Jansen, B. Hakvoort et al., Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders?, PEDIATRICS, vol.136, issue.2, pp.539-543, 2015.
DOI : 10.1542/peds.2014-4133

S. Akhondzadeh, S. Erfani, M. Mohammadi, M. Tehrani-doost, H. Amini et al., Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial, Journal of Clinical Pharmacy and Therapeutics, vol.85, issue.2, pp.145-50, 2004.
DOI : 10.1046/j.1440-1819.2003.01087.x

M. Hillbrand and K. Scott, The use of buspirone with aggressive behavior, Journal of Autism and Developmental Disorders, vol.51, issue.6, 1995.
DOI : 10.1007/BF02178195

N. Brahm, G. Fast, and R. Brown, Buspirone for Autistic Disorder in a Woman with an Intellectual Disability, Annals of Pharmacotherapy, vol.56, issue.1, pp.131-138, 2008.
DOI : 10.4088/JCP.v67n0311

A. Ghanizadeh and A. Ayoobzadehshirazi, A Randomized Double-Blind Placebo-Controlled Clinical Trial of Adjuvant Buspirone for Irritability in Autism, Pediatric Neurology, vol.52, issue.1, pp.77-81
DOI : 10.1016/j.pediatrneurol.2014.09.017

C. Sandman and A. Kemp, Opioid Antagonists May Reverse Endogenous Opiate " Dependence " in the Treatment of Self-Injurious Behavior. Pharmaceuticals, pp.366-81, 2011.

M. Leboyer, P. A. Bouvard, M. Guilloud-bataille, M. Bondoux, D. Tabuteau et al., Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives, Biological Psychiatry, vol.45, issue.2, pp.158-63, 1999.
DOI : 10.1016/S0006-3223(97)00532-5

S. Willemsen-swinkels, J. Buitelaar, F. Weijnen, and H. Van-engeland, Placebo-controlled acute dosage naltrexone study in young autistic children, Psychiatry Research, vol.58, issue.3, pp.203-218, 1995.
DOI : 10.1016/0165-1781(95)02749-M

S. Desjardins, C. Doyen, Y. Contejean, K. Kaye, and P. Paubel, Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form], pp.168-72, 2009.

F. Symons, A. Thompson, and M. Rodriguez, Self-injurious behavior and the efficacy of naltrexone treatment: A quantitative synthesis, Mental Retardation and Developmental Disabilities Research Reviews, vol.97, issue.3, pp.193-200, 2004.
DOI : 10.1001/archpsyc.1995.03950210060011

P. Hazell, Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. J Paediatr Child Health, Feb, vol.43, issue.12, pp.19-24, 2007.

B. Handen, C. Johnson, and M. Lubetsky, Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder, Journal of Autism and Developmental Disorders, vol.30, issue.3, pp.245-55, 2000.
DOI : 10.1023/A:1005548619694

D. Pearson, C. Santos, M. Aman, L. Arnold, C. Casat et al., Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms, Journal of Child and Adolescent Psychopharmacology, vol.23, issue.5, pp.337-51, 2013.
DOI : 10.1089/cap.2012.0096

K. Stigler, L. Desmond, D. Posey, R. Wiegand, and C. Mcdougle, A Naturalistic Retrospective Analysis of Psychostimulants in Pervasive Developmental Disorders, Journal of Child and Adolescent Psychopharmacology, vol.14, issue.1, pp.49-56, 2004.
DOI : 10.1089/104454604773840481

J. Kerbeshian, L. Burd, and W. Fisher, Lithium Carbonate in the Treatment of Two Patients with Infantile Autism and Atypical Bipolar Symptomatology, Journal of Clinical Psychopharmacology, vol.7, issue.6, pp.401-406, 1987.
DOI : 10.1097/00004714-198712000-00005

R. Steingard and J. Biederman, Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad Child Adolesc Psychiatry, pp.932-937, 1987.

E. Hollander, L. Soorya, S. Wasserman, K. Esposito, W. Chaplin et al., Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder, The International Journal of Neuropsychopharmacology, vol.9, issue.02, pp.209-222, 2006.
DOI : 10.1017/S1461145705005791

E. Hollander, W. Chaplin, L. Soorya, S. Wasserman, S. Novotny et al., Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, pp.990-998, 2010.

S. Wasserman, R. Iyengar, W. Chaplin, D. Watner, S. Waldoks et al., Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study, International Clinical Psychopharmacology, vol.21, issue.6, pp.363-370, 2006.
DOI : 10.1097/01.yic.0000224787.13782.0f

K. Belsito, P. Law, K. Kirk, R. Landa, and A. Zimmerman, Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial, Journal of Autism and Developmental Disorders, vol.31, issue.2, pp.175-81, 2001.
DOI : 10.1023/A:1010799115457

J. Halperin, J. Kalmar, K. Schulz, D. Marks, V. Sharma et al., Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys. J Am Acad Child Adolesc Psychiatry, pp.833-873, 2006.

A. Johansson, A. Bergvall, and S. Hansen, Behavioral disinhibition following basal forebrain excitotoxin lesions: alcohol consumption, defensive aggression, impulsivity and serotonin levels, Behavioural Brain Research, vol.102, issue.1-2, pp.17-29, 1999.
DOI : 10.1016/S0166-4328(98)00159-4

C. Gordon, R. State, J. Nelson, S. Hamburger, and J. Rapoport, A Double-blind Comparison of Clomipramine, Desipramine, and Placebo in the Treatment of Autistic Disorder, Archives of General Psychiatry, vol.50, issue.6, 1993.
DOI : 10.1001/archpsyc.1993.01820180039004

E. Hollander, A. Phillips, W. Chaplin, K. Zagursky, S. Novotny et al., A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, pp.582-591, 2005.

C. Mcdougle, S. Naylor, D. Cohen, F. Volkmar, G. Heninger et al., A double-blind, placebocontrolled study of fluvoxamine in adults with autistic disorder Arch Gen Psychiatry, 1996.

C. Mcdougle, L. Kresch, and D. Posey, Repetitive Thoughts and Behavior in Pervasive Developmental Disorders, J Autism Dev Disord, vol.30, issue.5, pp.427-462, 2000.
DOI : 10.1007/978-1-4615-5369-4_13

R. Nikolov, J. Jonker, and L. Scahill, Autistic disorder: current psychopharmacological treatments and areas of interest for future developments]. Rev Bras Psiquiatr Sao Paulo Braz, pp.39-46, 1999.

C. Mcdougle, E. Brodkin, S. Naylor, D. Carlson, D. Cohen et al., Sertraline in Adults With Pervasive Developmental Disorders, Journal of Clinical Psychopharmacology, vol.18, issue.1, pp.62-68, 1998.
DOI : 10.1097/00004714-199802000-00010

E. Brodkin, C. Mcdougle, S. Naylor, D. Cohen, and L. Price, Clomipramine in Adults with Pervasive Developmental Disorders: A Prospective Open-Label Investigation, Journal of Child and Adolescent Psychopharmacology, vol.7, issue.2, pp.109-130, 1997.
DOI : 10.1089/cap.1997.7.109

N. Pinninti and J. De-leon, Interaction of Sertraline With Clozapine, Journal of Clinical Psychopharmacology, vol.17, issue.2, 1997.
DOI : 10.1097/00004714-199704000-00012

F. Centorrino, R. Baldessarini, J. Kando, F. Frankenburg, S. Volpicelli et al., Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate, Am J Psychiatry, vol.151, issue.1, pp.123-128, 1994.

L. Anderson, M. Campbell, D. Grega, R. Perry, A. Small et al., Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms, Am J Psychiatry, 1984.

L. Anderson, M. Campbell, P. Adams, A. Small, R. Perry et al., The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children, Journal of Autism and Developmental Disorders, vol.12, issue.4, 1989.
DOI : 10.1176/ajp.123.1.32

M. Campbell, J. Armenteros, R. Malone, P. Adams, Z. Eisenberg et al., Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry, pp.835-878, 1997.

C. Mcdougle, K. Stigler, C. Erickson, and D. Posey, Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders, J Clin Psychiatry, vol.69, issue.4, pp.15-20, 2008.

M. Parikh, A. Kolevzon, and E. Hollander, Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability, Journal of Child and Adolescent Psychopharmacology, vol.18, issue.2, 2008.
DOI : 10.1089/cap.2007.0041

J. Mccracken, J. Mcgough, B. Shah, P. Cronin, D. Hong et al., Risperidone in Children with Autism and Serious Behavioral Problems, New England Journal of Medicine, vol.347, issue.5, pp.314-335, 2002.
DOI : 10.1056/NEJMoa013171

S. Shea, A. Turgay, A. Carroll, M. Schulz, H. Orlik et al., Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders, PEDIATRICS, vol.114, issue.5, pp.634-641, 2004.
DOI : 10.1542/peds.2003-0264-F

L. Scahill, K. Koenig, D. Carroll, and M. Pachler, Risperidone approved for the treatment of serious behavioral problems in children with autism. J Child Adolesc Psychiatr Nurs Off Publ Assoc Child Adolesc Psychiatr Nurses Inc, pp.188-90, 2007.

C. Mcdougle, J. Holmes, D. Carlson, G. Pelton, D. Cohen et al., A double-blind, placebocontrolled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry, pp.633-674, 1998.

C. Mcdougle, L. Scahill, M. Aman, J. Mccracken, E. Tierney et al., Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric Psychopharmacology, American Journal of Psychiatry, vol.162, issue.6, pp.1142-1150, 2005.
DOI : 10.1176/appi.ajp.162.6.1142

A. Martin, L. Scahill, G. Anderson, M. Aman, L. Arnold et al., Weight and Leptin Changes Among Risperidone-Treated Youths With Autism: 6-Month Prospective Data, American Journal of Psychiatry, vol.161, issue.6, 2004.
DOI : 10.1176/appi.ajp.161.6.1125

G. Anderson, L. Scahill, J. Mccracken, C. Mcdougle, M. Aman et al., Effects of shortand long-term risperidone treatment on prolactin levels in children with autism, Biol Psychiatry, 2007.

R. Marcus, R. Owen, L. Kamen, G. Manos, R. Mcquade et al., A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, vol.48, issue.11, pp.1110-1119, 2009.
DOI : 10.1097/CHI.0b013e3181b76658

R. Owen, L. Sikich, R. Marcus, P. Corey-lisle, G. Manos et al., Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder, PEDIATRICS, vol.124, issue.6, 2009.
DOI : 10.1542/peds.2008-3782

H. Ichikawa, K. Mikami, T. Okada, Y. Yamashita, Y. Ishizaki et al., Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study, Child Psychiatry & Human Development, vol.45, issue.Suppl 4, 2016.
DOI : 10.1007/s10578-013-0390-x

A. Ghanizadeh, A. Sahraeizadeh, and M. Berk, A Head-to-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial, Child Psychiatry & Human Development, vol.89, issue.5, pp.185-92, 2014.
DOI : 10.1016/j.clinthera.2012.02.023

E. Hollander, S. Wasserman, E. Swanson, W. Chaplin, M. Schapiro et al., ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder, Journal of Child and Adolescent Psychopharmacology, vol.16, issue.5, pp.541-549, 2006.
DOI : 10.1089/cap.2006.16.541

A. Loebel, M. Brams, R. Goldman, R. Silva, D. Hernandez et al., Lurasidone for the Treatment of Irritability Associated with Autistic Disorder, Journal of Autism and Developmental Disorders, vol.53, issue.12 suppl, pp.1153-63
DOI : 10.1016/j.jaac.2013.10.013

L. Mcclellan, K. Dominick, E. Pedapati, L. Wink, and C. Erickson, Lurasidone for the treatment of irritability and anger in autism spectrum disorders, Expert Opinion on Investigational Drugs, vol.9, issue.8, pp.985-994, 2017.
DOI : 10.1089/cap.2014.0158

C. Mcdougle, D. Kem, and D. Posey, Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry, pp.921-928, 2002.

S. Cohen, B. Fitzgerald, S. Khan, and A. Khan, The Effect of a Switch to Ziprasidone in an Adult Population With Autistic Disorder, The Journal of Clinical Psychiatry, vol.65, issue.1, pp.110-113, 2004.
DOI : 10.4088/JCP.v65n0119

R. Malone, M. Delaney, S. Hyman, and J. Cater, Ziprasidone in Adolescents with Autism: An Open-Label Pilot Study, Journal of Child and Adolescent Psychopharmacology, vol.17, issue.6, pp.779-90, 2007.
DOI : 10.1089/cap.2006.0126

K. Dominick, L. Wink, C. Mcdougle, and C. Erickson, A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder, Journal of Child and Adolescent Psychopharmacology, vol.25, issue.5, 2015.
DOI : 10.1089/cap.2014.0111

A. Martin, K. Koenig, L. Scahill, and J. Bregman, Open-Label Quetiapine in the Treatment of Children and Adolescents with Autistic Disorder, Journal of Child and Adolescent Psychopharmacology, vol.9, issue.2, pp.99-107, 1999.
DOI : 10.1089/cap.1999.9.99

P. Golubchik, J. Sever, and A. Weizman, Low-Dose Quetiapine for Adolescents With Autistic Spectrum Disorder and Aggressive Behavior, Clinical Neuropharmacology, vol.34, issue.6, pp.216-225, 2011.
DOI : 10.1097/WNF.0b013e31823349ac

D. Naber and H. Hippius, The European Experience With Use of Clozapine, Psychiatric Services, vol.41, issue.8, pp.886-90, 1990.
DOI : 10.1176/ps.41.8.886

J. Kane, G. Honigfeld, J. Singer, and H. Meltzer, Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry, pp.789-96, 1988.

M. Chakos, J. Lieberman, E. Hoffman, D. Bradford, and B. Sheitman, Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials, American Journal of Psychiatry, vol.158, issue.4, pp.518-544, 2001.
DOI : 10.1176/appi.ajp.158.4.518

S. Leucht, K. Komossa, C. Rummel-kluge, C. Corves, H. Hunger et al., A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia, American Journal of Psychiatry, vol.166, issue.2, pp.152-63, 2009.
DOI : 10.1176/appi.ajp.2008.08030368

J. Mcevoy, J. Lieberman, T. Stroup, S. Davis, H. Meltzer et al., Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment, American Journal of Psychiatry, vol.163, issue.4, pp.600-610, 2006.
DOI : 10.1176/ajp.2006.163.4.600

M. Juarez-reyes, M. Shumway, C. Battle, P. Bacchetti, M. Hansen et al., Effects of stringent criteria on eligibility for clozapine among public mental health clients, Psychiatr Serv Wash DC, 1995.

R. Buchanan, J. Kreyenbuhl, D. Kelly, J. Noel, D. Boggs et al., The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements, Schizophrenia Bulletin, vol.57, issue.8, pp.71-93, 2010.
DOI : 10.1176/appi.ps.57.8.1094

C. Frogley, D. Taylor, G. Dickens, and M. Picchioni, A systematic review of the evidence of clozapine's anti-aggressive effects, The International Journal of Neuropsychopharmacology, vol.60, issue.09, pp.1351-71, 2012.
DOI : 10.1001/jama.2009.675

A. Mallya, P. Roos, and K. Roebuck-colgan, Restraint, seclusion, and clozapine, J Clin Psychiatry, vol.53, issue.11, pp.395-402, 1992.

K. Chengappa, J. Vasile, J. Levine, R. Ulrich, R. Baker et al., Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital, Schizophrenia Research, vol.53, issue.1-2, pp.1-6, 2002.
DOI : 10.1016/S0920-9964(00)00175-4

H. Meltzer, L. Alphs, A. Green, A. Altamura, R. Anand et al., Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Arch Gen Psychiatry, pp.82-91, 2003.

R. Weitoft, G. Berglund, M. Lindström, E. Nilsson, M. Salmi et al., Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study, Pharmacoepidemiology and Drug Safety, vol.55, issue.B, pp.290-298, 2014.
DOI : 10.1177/1359786810385490

L. Citrome, J. Volavka, P. Czobor, B. Sheitman, J. Lindenmayer et al., Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol on Hostility Among Patients With Schizophrenia, Psychiatric Services, vol.52, issue.11, pp.1510-1514, 2001.
DOI : 10.1176/appi.ps.52.11.1510

M. Krakowski, P. Czobor, L. Citrome, N. Bark, and T. Cooper, Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry, 2006.

M. Sabaawi, N. Singh, and J. De-leon, Guidelines for the use of clozapine in individuals with developmental disabilities, Research in Developmental Disabilities, vol.27, issue.3, pp.309-345, 2006.
DOI : 10.1016/j.ridd.2005.05.002

R. Hammock, S. Schroeder, and W. Levine, The effect of clozapine on self-injurious behavior, Journal of Autism and Developmental Disorders, vol.12, issue.6, pp.611-637, 1995.
DOI : 10.1016/0005-7967(66)90024-6

A. J. Rush and F. A. , Expert Consensus Guideline Series: Treatment of psychiatric and behavioral problems in mental retardation, Am J Ment Retard AJMR, vol.105, issue.3, pp.159-226, 2000.

J. De-leon, Polydipsia--a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci, Feb, vol.253, issue.1, pp.37-46, 2003.

S. Leucht, K. Wahlbeck, J. Hamann, and W. Kissling, New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis, The Lancet, vol.361, issue.9369, pp.1581-1590, 2003.
DOI : 10.1016/S0140-6736(03)13306-5

L. Peacock, T. Solgaard, H. Lublin, and J. Gerlach, Clozapine versus typical antipsychotics. A retro-and prospective study of extrapyramidal side effects. Psychopharmacology (Berl), pp.188-96, 1996.

F. Mustafa, J. Burke, S. Abukmeil, J. Scanlon, and M. Cox, ???Schizophrenia past Clozapine???: Reasons for Clozapine Discontinuation, Mortality, and Alternative Antipsychotic Prescribing, Pharmacopsychiatry, vol.48, issue.01, pp.11-15, 2015.
DOI : 10.1055/s-0034-1394397

K. Hibbard, A. Propst, D. Frank, and J. Wyse, Fatalities Associated With Clozapine-Related Constipation and Bowel Obstruction: A Literature Review and Two Case Reports, Psychosomatics, vol.50, issue.4, pp.416-425, 2009.
DOI : 10.1176/appi.psy.50.4.416

J. Newcomer, Antipsychotic medications: metabolic and cardiovascular risk, J Clin Psychiatry, vol.68, issue.4, pp.8-13, 2007.

W. Wilson and A. Claussen, Seizures associated with clozapine treatment in a state hospital, J Clin Psychiatry, vol.55, issue.5, pp.184-192, 1994.

G. Laroche, D. Gaillard, and A. , Induced Obsessive Compulsive Symptoms (OCS) in schizophrenia patients under Atypical 2 Antipsychotics (AAPs): review and hypotheses, Psychiatry Research, vol.246, pp.119-147, 2016.
DOI : 10.1016/j.psychres.2016.09.031

M. Iqbal, A. Rahman, Z. Husain, S. Mahmud, W. Ryan et al., Clozapine: A Clinical Review of Adverse Effects and Management, Annals of Clinical Psychiatry, vol.15, issue.1, 2003.
DOI : 10.3109/10401230309085668

D. Miller, Review and management of clozapine side effects, J Clin Psychiatry, vol.61, issue.8, pp.14-17, 2000.

E. Carrizo, V. Fernández, L. Connell, I. Sandia, D. Prieto et al., Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14??week, double-blind, parallel group, placebo-controlled study, Schizophrenia Research, vol.113, issue.1, pp.19-26, 2009.
DOI : 10.1016/j.schres.2009.05.007

J. Alvir, J. Lieberman, A. Safferman, J. Schwimmer, and J. Schaaf, Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States, New England Journal of Medicine, vol.329, issue.3, pp.162-169, 1993.
DOI : 10.1056/NEJM199307153290303

D. Merrill, G. Dec, and D. Goff, Adverse Cardiac Effects Associated With Clozapine, Journal of Clinical Psychopharmacology, vol.25, issue.1, pp.32-41, 2005.
DOI : 10.1097/01.jcp.0000150217.51433.9f

S. Arias, P. Cohen, and J. Kwon, Clozapine-Induced Lymphocytic Alveolitis, American Journal of Psychiatry, vol.168, issue.2, pp.210-211, 2011.
DOI : 10.1176/appi.ajp.2010.10101494

J. Bayard, O. Descamps, S. Evrard, J. Dumonceau, L. Servais et al., Case report: acute pancreatitis induced by Clozapine, Acta Gastro-Enterol Belg, vol.68, issue.1, pp.92-96, 2005.

A. Chang, D. Krygier, N. Chatur, and E. Yoshida, Clozapine-Induced Fatal Fulminant Hepatic Failure: A Case Report, Canadian Journal of Gastroenterology, vol.23, issue.5, pp.376-384, 2009.
DOI : 10.1155/2009/503916

URL : http://doi.org/10.1155/2009/503916

J. Kanofsky, M. Woesner, A. Harris, J. Kelleher, K. Gittens et al., A Case of Acute Renal Failure in a Patient Recently Treated With Clozapine and a Review of Previously Reported Cases, The Primary Care Companion For CNS Disorders, vol.13, issue.3, 2011.
DOI : 10.4088/PCC.10br01091

K. Linsley and O. Williams, Clozapine-Associated Colitis, Journal of Clinical Psychopharmacology, vol.32, issue.4, pp.564-570
DOI : 10.1097/JCP.0b013e31825de1dd

J. Trollor, X. Chen, and P. Sachdev, Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs, CNS Drugs, vol.135, issue.3, pp.477-92, 2009.
DOI : 10.1016/S0025-7125(16)30278-4

A. Rami, D. Barkan, D. Mevorach, E. Leitersdorf, and Y. Caraco, Clozapine-Induced Systemic Lupus Erythematosus, Annals of Pharmacotherapy, vol.13, issue.5, pp.983-988, 2006.
DOI : 10.1038/clpt.1981.154

J. Tiihonen, J. Lönnqvist, K. Wahlbeck, T. Klaukka, L. Niskanen et al., 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study), The Lancet, vol.374, issue.9690, pp.620-627, 2009.
DOI : 10.1016/S0140-6736(09)60742-X

R. Hayes, J. Downs, C. Chang, R. Jackson, H. Shetty et al., The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders, Schizophrenia Bulletin, vol.29, issue.3, pp.644-55
DOI : 10.1017/S0033291798008186

O. Howes, F. Vergunst, S. Gee, P. Mcguire, S. Kapur et al., Conclusions, British Journal of Psychiatry, vol.201, issue.06, pp.481-486, 2012.
DOI : 10.1192/bjp.bp.111.105833